The United States Agency for International Development (USAID) has announced a $2.3 million commitment to purchase malaria treatment tablets, a significant boost for public health efforts in Nigeria.
This announcement was made via a statement issued by the United States (US) embassy in Abuja, Nigeria, on Tuesday, November 12.
This procurement, to be facilitated through the U.S. Government’s President’s Malaria Initiative (PMI), underscores the United States’ dedication to advancing Nigeria’s healthcare infrastructure and ensuring life-saving treatments reach vulnerable communities.
“The U.S. Agency for International Development (USAID) has committed $2.3 million to procure 4.8 million doses of life-saving malaria tablets from Swiss Pharma (Swipha) in a landmark partnership that will expand access to essential medicines in Nigeria and West Africa,” the statement read.
USAID’s investment highlights an ongoing focus on providing life-saving treatments to communities…